Kpj Healthcare Bhd (XKLS:5878) 5-Year EBITDA Growth Rate: 16.80% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:5878 Kpj Healthcare Bhd XKLS:5878
76 GF Score
Price RM2.70
GF Value RM2.77
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Kpj Healthcare Bhd 5-Year EBITDA Growth Rate?

Kpj Healthcare Bhd XKLS:5878 +3.45% 76 5-Year EBITDA Growth Rate is 16.80% as of Jun. 2026. GuruFocus rates XKLS:5878 with a GF Score™ of 76/100 and a GF Value™ of RM2.77 (Fairly Valued). The stock has 3 warning signs investors should review.

Kpj Healthcare Bhd's EBITDA per Share for the three months ended in Jun. 2026 was RM0.07.

During the past 12 months, Kpj Healthcare Bhd's average EBITDA Per Share Growth Rate was 8.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 12.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 16.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kpj Healthcare Bhd was 23.60% per year. The lowest was -0.70% per year. And the median was 8.70% per year.


Kpj Healthcare Bhd  (XKLS:5878) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Kpj Healthcare Bhd 5-Year EBITDA Growth Rate Related Terms


XKLS:5878 vs HCA, THC, EHC: 5-Year EBITDA Growth Rate Comparison

For the Medical Care Facilities subindustry, Kpj Healthcare Bhd's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kpj Healthcare Bhd 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kpj Healthcare Bhd's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kpj Healthcare Bhd's 5-Year EBITDA Growth Rate falls into.


XKLS:5878
76GF Score
Kpj Healthcare Bhd XKLS:5878
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kpj Healthcare Bhd 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 16.80% mean?
Kpj Healthcare Bhd (XKLS:5878) has a 5-Year EBITDA Growth Rate of 16.80% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Kpj Healthcare Bhd and its competitors.
Is Kpj Healthcare Bhd's 5-Year EBITDA Growth Rate too high?
Kpj Healthcare Bhd's current 5-Year EBITDA Growth Rate is 16.80%. Overall, Kpj Healthcare Bhd has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kpj Healthcare Bhd's 5-Year EBITDA Growth Rate compare to HCA and THC?
Kpj Healthcare Bhd's 5-Year EBITDA Growth Rate of 16.80% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Kpj Healthcare Bhd and its competitors. Kpj Healthcare Bhd's current 5-Year EBITDA Growth Rate is 16.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kpj Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kpj Healthcare Bhd (XKLS:5878) is currently considered Fairly Valued. The stock's GF Value™ is RM2.77, compared to a current price of RM2.70 — trading 2.5% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 16.80%. Kpj Healthcare Bhd's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Kpj Healthcare Bhd (XKLS:5878), the current 5-Year EBITDA Growth Rate is 16.80% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kpj Healthcare Bhd (XKLS:5878) Overvalued in 2026?

Based on GuruFocus' analysis, Kpj Healthcare Bhd stock appears to be undervalued. The current stock price of RM2.70 is trading 2.5% below its estimated GF Value™ of RM2.77. GuruFocus considers Kpj Healthcare Bhd to be Fairly Valued.

Key valuation signals for XKLS:5878:

  • 5-Year EBITDA Growth Rate: 16.80%
  • GF Value™: RM2.77 vs. price of RM2.70 (2.5% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the XKLS:5878 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kpj Healthcare Bhd Business Description

Address 238, Jalan Tun Razak, Level 12, Menara KPJ, Wilayah Persekutuan, Kuala Lumpur, MYS, 50400
KPJ Healthcare Bhd operates as an investment holding company and provides management services to its subsidiaries. The principal activities of the subsidiaries are mainly the operation of specialist hospitals. The reportable segments of the company are: (i) Malaysia - All healthcare activities including the private hospitals, pathology and laboratory services and distribution of pharmaceutical, medical and consumer healthcare products. (ii) Others - Operating segments involved in provision of hospital and retirement village services in Thailand and Australia, a private university and colleges of nursing and allied health and other similar activities in Malaysia. The majority of revenue is derived from the Malaysia segment.
76GF Score

Get the complete analysis for XKLS:5878

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM2.70
Price
RM2.77
GF Value